Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bioanalytical Systems, Inc. to Present at Wall Street Analyst Forum on February 11, 2002.


Business Editors & Health/Medical Writers

BIOWIRE2K

WEST LAFAYETTE West Lafayette, city (1990 pop. 25,907), Tippecanoe co., W Ind., a suburb of Lafayette, on the Wabash River; inc. 1924. A primarily residential city, it is the seat of Purdue Univ. , Ind.--(BW HealthWire)--Feb. 4, 2002

Bioanalytical Systems, Inc. (Nasdaq:BASI) today announced that Company management will make a presentation to analysts and portfolio managers at The Wall Street Analyst Forum's Institutional Investor Institutional Investor

A non-bank person or organization that trades securities in large enough share quantities or dollar amounts that they qualify for preferential treatment and lower commissions.
 Conference in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
 on Tuesday, February 11, 2002 at 10:10 a.m. Eastern time. Approximately 100 public companies will be presenting at the Conference from February 11, 2002 through February 14, 2002.

Analysts and portfolio managers who wish to attend the presentation should contact The Wall Street Analyst Forum at (802)-253-7596 to request additional information. Investors may access an Internet webcast of the presentation at: http://media.corporate-ir.net/media_files/priv/wsaf/event/021102.htm.

Bioanalytical Systems, Inc. is a pharmaceutical development company who provides contract research services and analytical systems to leading global pharmaceutical, drug development and medical device companies. The company focuses on developing innovative services and products that increase efficiency and reduce costs associated with taking new drugs to market. They have contributed to several billion dollars in annual sales of drugs for the treatment of central nervous system disorders Nervous system disorders

A satisfactory classification of diseases of the nervous system should include not only the type of reaction (congenital malformation, infection, trauma, neoplasm, vascular diseases, and degenerative, metabolic, toxic, or deficiency
 such as Alzheimer's and Parkinson's diseases Parkinson's disease or Parkinsonism, degenerative brain disorder first described by the English surgeon James Parkinson in 1817. When there is no known cause, the disease usually appears after age 40 and is referred to as Parkinson's disease. , diabetes, osteoporosis, HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  and other diseases.

A complete profile of Bioanalytical Systems, Inc. can be viewed at www.bioanalytical.com/invest.html.

This release contains forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to the development of products and services, changes in technology, industry standards and regulatory standards, and various market and operating risks detailed in the company's filings with the Securities and Exchange Commission.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 4, 2002
Words:270
Previous Article:FAR&WIDE Escorted Tours Showcase the Ambiance of France.
Next Article:Delta Faucet Company Names Jay Burnett VP-Engineering; 20-year Company Veteran Tabbed for Top Engineering Slot.
Topics:



Related Articles
Universal American Financial Corp. to Present At Upcoming Investment Conferences in New York City.
Patricia Costante, CEO of The MIIX Group, Will be Presenting At The Wall Street Analyst Forum on February 11, 2002.
ADVISORY/ CMGI Chief Financial Officer, George McMillan, to Present at Wall Street Analyst Forum, February 11, 2002.
Pharsight CEO Arthur Reidel to Present Company Overview at The Wall Street Analyst Forum, February 11, 2002.
Paradyne to Present At The Wall Street Analyst Forum's Institutional Investor Conference.
NEXIQ Technologies Chairman and CEO, John R. Allard, to Present At the Wall Street Analyst Forum.
REMINDER/ CMGI Chief Financial Officer, George McMillan, to Present at Wall Street Analyst Forum, February 11, 2002.
Crosswave, Bioanalytical Systems, Internet Initiative Japan, and Berry Petroleum Events to be Broadcast by Vcall Over the Internet.
Bioanalytical Systems, Inc. To Host First Quarter Conference Call on Tuesday, February 11.
First Quarter 2003 Revenue Increase at Bioanalytical Systems, Inc.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles